Logo image of AMTM

AMENTUM HOLDINGS INC (AMTM) Stock Fundamental Analysis

USA - NYSE:AMTM - US0239391016 - Common Stock

22.63 USD
+0.07 (+0.31%)
Last: 9/24/2025, 1:22:33 PM
Fundamental Rating

3

Overall AMTM gets a fundamental rating of 3 out of 10. We evaluated AMTM against 81 industry peers in the Professional Services industry. Both the profitability and financial health of AMTM have multiple concerns. A decent growth rate in combination with a cheap valuation! Better keep an eye on AMTM.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

AMTM had positive earnings in the past year.
In the past year AMTM had a positive cash flow from operations.
AMTM Yearly Net Income VS EBIT VS OCF VS FCFAMTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 100M -100M 200M -200M -300M

1.2 Ratios

AMTM has a worse Return On Assets (0.44%) than 60.49% of its industry peers.
AMTM's Return On Equity of 1.17% is on the low side compared to the rest of the industry. AMTM is outperformed by 60.49% of its industry peers.
With a Return On Invested Capital value of 2.48%, AMTM is not doing good in the industry: 61.73% of the companies in the same industry are doing better.
Measured over the past 3 years, the Average Return On Invested Capital for AMTM is significantly below the industry average of 12.93%.
The 3 year average ROIC (2.31%) for AMTM is below the current ROIC(2.48%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.44%
ROE 1.17%
ROIC 2.48%
ROA(3y)-2.27%
ROA(5y)N/A
ROE(3y)-33%
ROE(5y)N/A
ROIC(3y)2.31%
ROIC(5y)N/A
AMTM Yearly ROA, ROE, ROICAMTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

AMTM has a Profit Margin of 0.41%. This is comparable to the rest of the industry: AMTM outperforms 40.74% of its industry peers.
The Operating Margin of AMTM (2.39%) is comparable to the rest of the industry.
AMTM's Operating Margin has been stable in the last couple of years.
Looking at the Gross Margin, with a value of 10.21%, AMTM is doing worse than 83.95% of the companies in the same industry.
In the last couple of years the Gross Margin of AMTM has declined.
Industry RankSector Rank
OM 2.39%
PM (TTM) 0.41%
GM 10.21%
OM growth 3Y-0.75%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.94%
GM growth 5YN/A
AMTM Yearly Profit, Operating, Gross MarginsAMTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 5 10

2

2. Health

2.1 Basic Checks

AMTM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for AMTM has been increased compared to 1 year ago.
AMTM has a better debt/assets ratio than last year.
AMTM Yearly Shares OutstandingAMTM Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 50M 100M 150M 200M
AMTM Yearly Total Debt VS Total AssetsAMTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of 1.67, we must say that AMTM is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.67, AMTM is doing worse than 71.60% of the companies in the same industry.
AMTM has a debt to FCF ratio of 32.53. This is a negative value and a sign of low solvency as AMTM would need 32.53 years to pay back of all of its debts.
The Debt to FCF ratio of AMTM (32.53) is worse than 66.67% of its industry peers.
A Debt/Equity ratio of 1.00 indicates that AMTM is somewhat dependend on debt financing.
AMTM's Debt to Equity ratio of 1.00 is on the low side compared to the rest of the industry. AMTM is outperformed by 67.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 1
Debt/FCF 32.53
Altman-Z 1.67
ROIC/WACC0.29
WACC8.7%
AMTM Yearly LT Debt VS Equity VS FCFAMTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 1.58 indicates that AMTM should not have too much problems paying its short term obligations.
The Current ratio of AMTM (1.58) is comparable to the rest of the industry.
AMTM has a Quick Ratio of 1.58. This is a normal value and indicates that AMTM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.58, AMTM is in the better half of the industry, outperforming 61.73% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.58
AMTM Yearly Current Assets VS Current LiabilitesAMTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

AMTM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 83.53%, which is quite impressive.
Looking at the last year, AMTM shows a small growth in Revenue. The Revenue has grown by 6.65% in the last year.
Measured over the past years, AMTM shows a quite strong growth in Revenue. The Revenue has been growing by 12.53% on average per year.
EPS 1Y (TTM)83.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%124.64%
Revenue 1Y (TTM)6.65%
Revenue growth 3Y12.53%
Revenue growth 5YN/A
Sales Q2Q%66.25%

3.2 Future

The Earnings Per Share is expected to grow by 72.63% on average over the next years. This is a very strong growth
AMTM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.51% yearly.
EPS Next Y317.31%
EPS Next 2Y114.95%
EPS Next 3Y72.63%
EPS Next 5YN/A
Revenue Next Year2.65%
Revenue Next 2Y1.82%
Revenue Next 3Y2.51%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AMTM Yearly Revenue VS EstimatesAMTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B
AMTM Yearly EPS VS EstimatesAMTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.5 1 1.5 2 2.5

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 10.93, which indicates a very decent valuation of AMTM.
AMTM's Price/Earnings ratio is rather cheap when compared to the industry. AMTM is cheaper than 87.65% of the companies in the same industry.
AMTM's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.41.
AMTM is valuated reasonably with a Price/Forward Earnings ratio of 9.23.
Based on the Price/Forward Earnings ratio, AMTM is valued cheaper than 88.89% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of AMTM to the average of the S&P500 Index (22.87), we can say AMTM is valued rather cheaply.
Industry RankSector Rank
PE 10.93
Fwd PE 9.23
AMTM Price Earnings VS Forward Price EarningsAMTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AMTM indicates a somewhat cheap valuation: AMTM is cheaper than 69.14% of the companies listed in the same industry.
AMTM's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 39.95
EV/EBITDA 12.28
AMTM Per share dataAMTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AMTM's earnings are expected to grow with 72.63% in the coming years.
PEG (NY)0.03
PEG (5Y)N/A
EPS Next 2Y114.95%
EPS Next 3Y72.63%

0

5. Dividend

5.1 Amount

No dividends for AMTM!.
Industry RankSector Rank
Dividend Yield N/A

AMENTUM HOLDINGS INC

NYSE:AMTM (9/24/2025, 1:22:33 PM)

22.63

+0.07 (+0.31%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)12-16 2025-12-16
Inst Owners62.75%
Inst Owner Change4.41%
Ins Owners0.56%
Ins Owner Change0%
Market Cap5.51B
Analysts74.67
Price Target27.54 (21.7%)
Short Float %6.1%
Short Ratio6.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.54%
Min EPS beat(2)2.91%
Max EPS beat(2)10.16%
EPS beat(4)4
Avg EPS beat(4)26.92%
Min EPS beat(4)2.91%
Max EPS beat(4)84.31%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.42%
Min Revenue beat(2)-0.61%
Max Revenue beat(2)-0.23%
Revenue beat(4)2
Avg Revenue beat(4)0.41%
Min Revenue beat(4)-0.61%
Max Revenue beat(4)2.38%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.4%
PT rev (3m)7.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.63%
EPS NY rev (1m)0%
EPS NY rev (3m)1.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.46%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.32%
Valuation
Industry RankSector Rank
PE 10.93
Fwd PE 9.23
P/S 0.43
P/FCF 39.95
P/OCF 34.41
P/B 1.24
P/tB N/A
EV/EBITDA 12.28
EPS(TTM)2.07
EY9.15%
EPS(NY)2.45
Fwd EY10.83%
FCF(TTM)0.57
FCFY2.5%
OCF(TTM)0.66
OCFY2.91%
SpS52.11
BVpS18.32
TBVpS-13.29
PEG (NY)0.03
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.44%
ROE 1.17%
ROCE 3.14%
ROIC 2.48%
ROICexc 2.69%
ROICexgc 19.81%
OM 2.39%
PM (TTM) 0.41%
GM 10.21%
FCFM 1.09%
ROA(3y)-2.27%
ROA(5y)N/A
ROE(3y)-33%
ROE(5y)N/A
ROIC(3y)2.31%
ROIC(5y)N/A
ROICexc(3y)2.45%
ROICexc(5y)N/A
ROICexgc(3y)14.93%
ROICexgc(5y)N/A
ROCE(3y)2.92%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-0.75%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.94%
GM growth 5YN/A
F-Score6
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity 1
Debt/FCF 32.53
Debt/EBITDA 5.91
Cap/Depr 4.94%
Cap/Sales 0.17%
Interest Coverage 250
Cash Conversion 21.28%
Profit Quality 264.03%
Current Ratio 1.58
Quick Ratio 1.58
Altman-Z 1.67
F-Score6
WACC8.7%
ROIC/WACC0.29
Cap/Depr(3y)5.55%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.2%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)83.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%124.64%
EPS Next Y317.31%
EPS Next 2Y114.95%
EPS Next 3Y72.63%
EPS Next 5YN/A
Revenue 1Y (TTM)6.65%
Revenue growth 3Y12.53%
Revenue growth 5YN/A
Sales Q2Q%66.25%
Revenue Next Year2.65%
Revenue Next 2Y1.82%
Revenue Next 3Y2.51%
Revenue Next 5YN/A
EBIT growth 1Y16.17%
EBIT growth 3Y11.69%
EBIT growth 5YN/A
EBIT Next Year106.14%
EBIT Next 3Y31.79%
EBIT Next 5YN/A
FCF growth 1Y-30.5%
FCF growth 3Y-45.82%
FCF growth 5YN/A
OCF growth 1Y-30.26%
OCF growth 3Y-42.49%
OCF growth 5YN/A